AXECTITUDE

Details for Australian Trade Mark No. 909139 (hide)

Owner Bristol-Myers Squibb Company a Delaware corporation

Service SPRUSON & FERGUSON GPO Box 3898 SYDNEY NSW 2001 AUSTRALIA

Various Convention priority claimed: 10 December 2001, United States of America, No. 78/097504 in respect of PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES, CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS, STROKE, CANCER, IN

Classes

Class 5 Pharmaceutical preparations, including those for the treatment and prevention of cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases

Event Publications

1 November 2012 Trade Mark Removed from the Register / IR Expired

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

909140-LYSMATE

909138-K-Y LIQUID